Antti Palomäki1, Tuomas Kiviniemi1, Juha E K Hartikainen2, Pirjo Mustonen3, Antti Ylitalo4, Ilpo Nuotio5, Päivi Hartikainen2,6, Jussi Jaakkola1, Riho Luite2, K E Juhani Airaksinen1. 1. Heart Center, Turku University Hospital and University of Turku, Turku, Finland. 2. Heart Center, Kuopio University Hospital, Kuopio, Finland. 3. Department of Medicine, Keski-Suomi Central Hospital, Jyväskylä, Finland. 4. Heart Center, Satakunta Central Hospital, Pori, Finland. 5. Department of Medicine, Turku University Hospital and University of Turku, Turku, Finland. 6. NeuroCenter, Neurology Department, Kuopio University Hospital, Kuopio, Finland.
Abstract
BACKGROUND: Patients with atrial fibrillation (AF) frequently undergo invasive procedures. Optimal perioperative use of oral anticoagulation (OAC) and heparin bridging is not well defined. HYPOTHESIS: Discontinuation of OAC for minor procedures/operations places AF patients at risk for thromboembolism. METHODS: In this study, we assessed perioperative antithrombotic treatment in patients with AF who suffered a postoperative stroke or intracranial bleeding. The FibStroke Study includes AF patients with an ischemic stroke or intracranial bleed identified from the discharge registries of 4 Finnish hospitals. In total, 3632 consecutive patients developed 3252 ischemic strokes and 794 intracranial bleeds. All invasive procedures during the 30 days preceding the stroke or intracranial bleed were identified. RESULTS: A total of 194/3252 (6.0%) ischemic strokes and 23/794 (2.9%) intracranial bleeds were preceded by a procedure. Altogether, 69% of the patients were on OAC prior to index procedure, OAC was interrupted in 81.2% of the procedures preceding a stroke, and heparin bridging was used in 27.8% of interruptions. Of the procedures leading to stroke, 42.3% were low-bleeding-risk procedures, and OAC was interrupted in 84.7% of these procedures. The median time from procedure to stroke was 4 days. Heparin bridging was used in 54.5% of OAC interruptions preceding intracranial bleeding and combination of anticoagulation with antiplatelet therapy by 43.5% of patients with postoperative intracranial bleeding. CONCLUSIONS: Perioperative interruption of OAC is common in patients who suffer a postoperative stroke, even in patients with low-bleeding-risk procedures. Postoperative intracranial bleeding is frequently preceded by perioperative heparin bridging.
BACKGROUND:Patients with atrial fibrillation (AF) frequently undergo invasive procedures. Optimal perioperative use of oral anticoagulation (OAC) and heparin bridging is not well defined. HYPOTHESIS: Discontinuation of OAC for minor procedures/operations places AFpatients at risk for thromboembolism. METHODS: In this study, we assessed perioperative antithrombotic treatment in patients with AF who suffered a postoperative stroke or intracranial bleeding. The FibStroke Study includes AFpatients with an ischemic stroke or intracranial bleed identified from the discharge registries of 4 Finnish hospitals. In total, 3632 consecutive patients developed 3252 ischemic strokes and 794 intracranial bleeds. All invasive procedures during the 30 days preceding the stroke or intracranial bleed were identified. RESULTS: A total of 194/3252 (6.0%) ischemic strokes and 23/794 (2.9%) intracranial bleeds were preceded by a procedure. Altogether, 69% of the patients were on OAC prior to index procedure, OAC was interrupted in 81.2% of the procedures preceding a stroke, and heparin bridging was used in 27.8% of interruptions. Of the procedures leading to stroke, 42.3% were low-bleeding-risk procedures, and OAC was interrupted in 84.7% of these procedures. The median time from procedure to stroke was 4 days. Heparin bridging was used in 54.5% of OAC interruptions preceding intracranial bleeding and combination of anticoagulation with antiplatelet therapy by 43.5% of patients with postoperative intracranial bleeding. CONCLUSIONS: Perioperative interruption of OAC is common in patients who suffer a postoperative stroke, even in patients with low-bleeding-risk procedures. Postoperative intracranial bleeding is frequently preceded by perioperative heparin bridging.
Authors: Michelle A Anderson; Tamir Ben-Menachem; S Ian Gan; Vasundhara Appalaneni; Subhas Banerjee; Brooks D Cash; Laurel Fisher; M Edwyn Harrison; Robert D Fanelli; Norio Fukami; Steven O Ikenberry; Rajeev Jain; Khalid Khan; Mary Lee Krinsky; David R Lichtenstein; John T Maple; Bo Shen; Laura Strohmeyer; Todd Baron; Jason A Dominitz Journal: Gastrointest Endosc Date: 2009-11-03 Impact factor: 9.427
Authors: David H Birnie; Jeff S Healey; George A Wells; Atul Verma; Anthony S Tang; Andrew D Krahn; Christopher S Simpson; Felix Ayala-Paredes; Benoit Coutu; Tiago L L Leiria; Vidal Essebag Journal: N Engl J Med Date: 2013-05-09 Impact factor: 91.245
Authors: Jeff S Healey; John Eikelboom; James Douketis; Lars Wallentin; Jonas Oldgren; Sean Yang; Ellison Themeles; Hein Heidbuchel; Hein Heidbuchle; Alvaro Avezum; Paul Reilly; Stuart J Connolly; Salim Yusuf; Michael Ezekowitz Journal: Circulation Date: 2012-06-14 Impact factor: 29.690
Authors: K E Juhani Airaksinen; Fausto Biancari; Pasi Karjalainen; Reija Mikkola; Kari Kuttila; Pekka Porela; Timo Laitio; Gregory Y H Lip Journal: Thromb Res Date: 2011-06-17 Impact factor: 3.944
Authors: Antti-Pekka Annala; Pasi P Karjalainen; Pekka Porela; Kai Nyman; Antti Ylitalo; K E Juhani Airaksinen Journal: Am J Cardiol Date: 2008-05-22 Impact factor: 2.778
Authors: Deborah Siegal; Jovana Yudin; Scott Kaatz; James D Douketis; Wendy Lim; Alex C Spyropoulos Journal: Circulation Date: 2012-08-21 Impact factor: 29.690